Abstract
The treatment of hookworm disease is still unsatisfactory and the search of newer and more effective drugs continues. Drugs currently employed against hookworm infection lack consistent efficacy at the desirable therapeutic levels against both the common species of the hookworm — Ancylostoma duodenale and Necator americanus, responsible for human hookworm disease. Recently, a new drug, bitoscanate — phenylene diisothiocyanate-1,4 — has been shown to be effective against a variety of nematodes, both in experimental animals and in man. This drug has also been shown to be effective against both the species of the hookworm.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Birkhäuser Verlag Basel
About this chapter
Cite this chapter
Mutalik, G.S., Gulati, R.B. (1975). Comparative Study of Bitoscanate, Bephenium hydroxynaphthoate and Tetrachlorethylene in Hookworm Disease. In: Jucker, E. (eds) Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, vol 19. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7090-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7090-0_12
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7092-4
Online ISBN: 978-3-0348-7090-0
eBook Packages: Springer Book Archive